The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma

Steven N. Steinway(Brigham and Women's Hospital), Wei Ding(Ministry of Education of the People's Republic of China)
PLoS ONE
May 22, 2015
Cited by 35


Related Papers